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The Nijmegen breakage syndrome 1 (Nbs1) subunit
of the Mre11-Rad50-Nbs1 (MRN) complex protects
genome integrity by coordinating double-strand
break (DSB) repair and checkpoint signaling through
undefined interactions with ATM, MDC1, and Sae2/
Ctp1/CtIP. Here, fission yeast and human Nbs1
structures defined by X-ray crystallography and
small angle X-ray scattering (SAXS) reveal Nbs1 car-
dinal features: fused, extended, FHA-BRCT1-BRCT2
domains flexibly linked to C-terminal Mre11- and
ATM-binding motifs. Genetic, biochemical, and
structural analyses of an Nbs1-Ctp1 complex show
Nbs1 recruits phosphorylated Ctp1 to DSBs via
binding of the Nbs1 FHA domain to a Ctp1 pThr-Asp
motif. Nbs1 structures further identify an extensive
FHA-BRCT interface, a bipartite MDC1-binding scaf-
fold, an extended conformational switch, and the
molecular consequences associated with cancer
predisposing Nijmegen breakage syndrome muta-
tions. Tethering of Ctp1 to a flexible Nbs1 arm
suggests a mechanism for restricting DNA end pro-
cessing and homologous recombination activities
of Sae2/Ctp1/CtIP to the immediate vicinity of DSBs.
INTRODUCTION
The Mre11-Rad50-Nbs1 (MRN) complex coordinates detection,
signaling, and repair of cytotoxic DNA double-strand breaks
(DSBs). Mutation of MRN subunits in Saccharomyces cerevisiaeand Schizosaccharomyces pombe causes genotoxin sensitivity
and meiotic defects resulting from defective processing of pro-
grammed DSBs (reviewed in Williams et al., 2007). In humans,
congenitally acquired hypomorphicNBS1 andMRE11mutations
cause radiosensitivity and chromosome instability syndromes,
Nijmegen breakage syndrome (NBS) and ataxia-telangiectasia-
like disorder (ATLD), respectively (Carney et al., 1998; Stewart
et al., 1999).
MRN possesses critical end-bridging and endonucleolytic
activities for homologous recombination (HR) repair of DSBs
(Williams et al., 2008). MRN also acts in checkpoint signaling
by targeting the ATM/Tel1 kinase to DSBs by binding Nbs1 C
terminus (Falck et al., 2005; You et al., 2005). ATM phosphory-
lates the histone H2AX C-terminal tail near DSBs to form the
gH2AX chromatin modification (Stucki and Jackson, 2006). In
mammals, checkpoint adaptor MDC1 binds gH2AX, facilitating
the intra-S phase checkpoint (Goldberg et al., 2003; Lou et al.,
2006; Stucki et al., 2005). MDC1 then recruits added MRN-
ATM complexes via phosphorylation-dependent interactions
with Nbs1 FHA-BRCT1-BRCT2 domains (Chapman and Jack-
son, 2008; Melander et al., 2008; Spycher et al., 2008; Wu
et al., 2008) to amplify or sustain checkpoint signals (Lou et al.,
2006). However, no MDC1 homologs are known in lower eukary-
otes, so other ancestral Nbs1 FHA-BRCT1-BRCT2 domain func-
tions likely exist.
MRN activities in HR involve the diverged protein known as
Ctp1 in S. pombe (Limbo et al., 2007), Sae2 in S. cerevisiae,
and CtIP in mammals (Sartori et al., 2007). Sae2 cleaves DNA
substrates in vitro (Lengsfeld et al., 2007), consistent with 50 to
30 single-strand resection of DSBs in vivo to generate 30 single-
stranded DNA tails for HR (Mimitou and Symington, 2008;
Zhuet al., 2008).Ctp1Sae2 is required for removal of proteins linked
to the 50 end of DSBs (Neale et al., 2005), including complexes
formed by the anticancer drug etoposide and topoisomerase IICell 139, 87–99, October 2, 2009 ª2009 Elsevier Inc. 87
Figure 1. Nbs1 N-terminal Domain Structure
(A) Nbs1 domain architecture schematic with flexible trypsin-accessible cleavage sites (‘‘T’’), Mre11-binding motif (‘‘MB’’), and ATM/Tel1-binding motif (‘‘AT’’).
(B) Trypsin degradation (done at 4Cwith indicated trypsin concentrations and 1 mg/ml Nbs1-DAT) maps a stable Nbs1 folded core (Nbs1-fc) to residues 1–329.
Transiently stable products map added cleavage sites to the Nbs1 central region.
(C) Nbs1-fc adopts an elongated structure with closely interacting FHA (blue), BRCT1 (yellow), and BRCT2 (brown) domains.
(D) The Nbs1 FHA-BRCT interface has extensive hydrophobic interactions.
(E) Two phosphoprotein-binding sites in the FHA and at the BRCT1-BRCT2 interface enable four Nbs1 protein-protein binding modes.(Hartsuiker et al., 2009). Ctp1Sae2 activities appear conserved in
mammals, and CtIP is a tumor suppressor in mice (Chen et al.,
2005). In human cells, CtIP interacts with MRN (Sartori et al.,
2007), and coprecipitates with Nbs1 when coexpressed in insect
cells, suggesting that CtIP binds Nbs1 (Chen et al., 2008), but the
mechanism and significance of this interaction are unknown.
Whereas microscopic and crystallographic analyses of Mre11
and Rad50 were integral in defining MRN DNA bridging and
nuclease processing activities (Hopfner et al., 2000, 2001, 2002;
Williams et al., 2008), how Nbs1 physically integrates DNA end
sensing and processing with cell-cycle checkpoint activation
remains a mystery. Here, we report combined structural and
functional dissection of fission yeast and human Nbs1. X-ray
structures and small-angle X-ray scattering (SAXS) results
show an S. pombe Nbs1 folded core is conserved in human88 Cell 139, 87–99, October 2, 2009 ª2009 Elsevier Inc.Nbs1 and that disease-associated Nbs1 mutations fall into the
folded N-terminal FHA-BRCT1-BRCT2 domains defined by our
structures. Our results further uncover the basis for phosphory-
lation-dependent recruitment of Ctp1 to DSBs by Nbs1. Nbs1
emerges as an extended, flexible binding nexus coordinating
interactions between the Mre11-Rad50 core, the checkpoint
kinase ATM/Tel1, and the DNA end-processing factor Ctp1.
RESULTS
Mapping Nbs1 Functional Domains
To define functional Nbs1 regions, we expressed a series of trun-
cated S. pombeNbs1 (spNbs1) proteins andmapped structured
domains with proteolysis (Figures 1A and 1B). Full-length
spNbs1 expresses at low levels in E. coli, but a 60 residue
C-terminal deletion (residues 1–553, Nbs1-DAT), removing the
ATM/Tel1-binding motif (AT) but retaining an Mre11-binding
consensus motif (MB) (Falck et al., 2005; You et al., 2005), facil-
itates robust recombinant overexpression. Trypsin degradation
of Nbs1-DAT reveals a stable 37 kDa folded core (Nbs1-fc, resi-
dues 1–329) encompassing the Nbs1 FHA domain and its two
BRCT domains (Figures 1A and 1B). N-terminal sequencing of
smaller transiently stable trypsin products maps three additional
cleavage sites to a divergent sequence linking BRCT2 and the
MB motif. Thus, the N-terminal 55% of spNbs1 comprises
a composite FHA-BRCT1-BRCT2 folded Nbs1-fc that is linked
to the C-terminal Mre11- and ATM-binding regions via
a protease-sensitive linker peptide. Like human Nbs1 (Difilippan-
tonio et al., 2005), but unlike S. cerevisiae Xrs2Nbs1 (Shima et al.,
2005), the integrity of S. pombe Nbs1-fc is critical for MRN
complex DSB repair functions (Figure S1 available online).
Nbs1 Folded Core Architecture and Structure
ToexamineNbs1structure and function,wedetermined the 2.8 A˚
resolution X-ray structure of spNbs1-fc with selenomethionine
multiwavelength anomalous dispersion (see the Experimental
Procedures), (Table S2 and Figure S2). Overall, Nbs1-fc is an
elongated, distorted cylinder with dimensions of 35 by 40 by
95 A˚, composed of joined FHA, BRCT1, and BRCT2 domains
(Figure 1C). FHA and BRCT repeat domains mediate phosphory-
lation-regulated protein interactions and are ubiquitous among
DNA repair proteins (Glover et al., 2004; Williams et al., 2004).
Like budding yeast Rad53-FHA1 (Durocher et al., 1999) ormurine
PNK-FHA (Bernstein et al., 2005), the Nbs1 FHA domain folds as
a canonical FHA b sandwich with two opposed five-stranded
antiparallel b sheets and distal variable phosphoprotein-interact-
ing b strand connector loops (Figure S3).
The tandem Nbs1 BRCT domains adopt BRCT a-b sandwich
folds with a central four-stranded parallel b sheet surrounded by
three to four helices and orient relative to one another with
a triple-helical hydrophobic inter-BRCT repeat interface.Although
similar in structure to hBRCA1 BRCT repeats (Williams et al.,
2001), the Nbs1 inter-BRCT repeat angle is offset by40 relative
to BRCA1 tandem BRCTs (Figure S4). Sequence comparisons
show that BRCT phosphoprotein interaction motifs (a conserved
S/T at theC terminus of the firstb sheet inBRCT1 (b11-a2 junction
in Nbs1), and a TXKmotif at the N terminus of the second helix in
the BRCT (a3 in Nbs1) (Clapperton et al., 2004; Williams et al.,
2004)) are absent in S. pombe Nbs1 but present in the human,
mouse, chicken, and frog Nbs1 homologs (Figure S3).
Despite similarities to known domain structures, key Nbs1
features suggest distinct functions in coordinating DNA repair
signaling pathways. Notably, Nbs1 is configured as a bipartite
binding scaffold to mediate association with phosphorylated
binding partners via four possible binding modes (Figure 1E):
FHA-only binding (class i), BRCT-only binding (class ii), simulta-
neous FHA and BRCT binding for alignment of two distinct
binding partners (class iii), or recognition of tandem phosphory-
lation clusters in one target protein via simultaneous FHA/BRCT
binding (class iv). The phosphoprotein-binding sites (spaced
80 A˚ apart) could be spanned by an 22 amino acid spacing
(3.8 A˚/residue) between phosphorylated residues within a single
protein.A defining Nbs1-fc feature is its extensive FHA-BRCT inter-
face. The FHA N and C termini pack at the FHA-BRCT1 interface
with N-terminal methionine and the invariant Trp2 buried within
the protein core (Figure S5A). Attachment of affinity or epitope
tags to the Nbs1 N terminus (data not shown) or a Trp2 to Ala
mutation renders spNbs1 nonfunctional in vivo, suggesting that
the FHA-BRCT1 interface is critical for structure and function
(Figure S5B). Close FHA and BRCT1 domain juxtaposition results
from a short two-residue linker between the FHA-b10 and
BRCT1-b1 strands, and by an Nbs1-specific helical insertion
(helix a1) between FHA b strands b5 and b6 (Figure 1D). At the
FHA-BRCT1 boundary, an uninterrupted network of hydrophobic
residues from the FHA (Met1, Ile17, Phe19, Cys66, Pro55),
BRCT1 (Met116, Leu136, Pro139, Ala147, Ser145, Arg143), and
two flanking salt-bridges (Lys14-Asp194 and Glu57-Arg143)
stabilize the FHA-BRCT1 interface. The large buried surface
area (2150 A˚2) for the FHA-BRCT1 interface suggests that the
relative positioning of the FHA-BRCT1-BRCT2 scaffold aligns
phosphoprotein interaction sites on opposite faces of Nbs1.
Human Nbs1 Solution Structure
To better understand NBS mutations, we analyzed the human
Nbs1-fc structure with SAXS and proteolysis. Human Nbs1
(hNbs1) forms a trypsin-stable composite FHA-BRCT1-BRCT2
core (hNbs1-fc, residues 1–334) similar to spNbs1-fc (Figure 2A).
As all parts of a structure contribute to the experimental X-ray
scattering, SAXS provides an objective, quantitative measure
of structural similarity (Putnam et al., 2007). SAXS data of
hNbs1-fc closely matches calculated scattering by the
spNbs1-fc X-ray structure (c2 = 2.00), revealing conservation
of structure despite low sequence conservation of Nbs1-fc
(11% identity, 25% similarity). Yet, structure-based sequence
alignments show an insertion missing in the spNbs1-fc model
corresponds to an a helix usually found between the third and
fourth BRCT domain b strands (b17 and b18 of BRCT2) that is
linked to an hNbs1 Ser278 phosphorylation site loop (human
Nbs1 residues 272–295) (Figure S3). To model these missing
regions of hNbs1-fc, we generated 100 hNbs1-fc models based
on the spNbs1 structure using MODELLER and evaluated
models by fit to the SAXS data. This approach identified 12
models with superior c2 fits (c2 < 1.3, best model c2 = 1.25)
that all bear extended accessible pSer278 loop conformations
(Figures 2B and 2C). Thus, the overall spNbs1-fc fold is main-
tained in hNbs1-fc but is decorated with a solvent-accessible
phosphorylated loop. Indeed, based on the BRCT1-BRCT2 inter-
face position and Ser278 accessibility on this loop, we hypothe-
size phosphorylated Ser278 in hNbs1 is suitably placed to
regulate BRCT phosphoprotein interactions in cis through an
intermolecular autoinhibitory mechanism (Figure 2C).
Nbs1 657del5 Mutation
Nbs1 SAXS and X-ray structures provide molecular insights into
the consequences of patient-derived NBS mutations. The
657del5 frameshift NBS predisposition mutation, accounting
for 90% of patient isolated mutations (Digweed and Sperling,
2004), generates a protein truncation plus a cryptic translational
start site fromwhich the Nbs1C terminus is produced at reduced
levels (Maser et al., 2001). This catastrophic molecularCell 139, 87–99, October 2, 2009 ª2009 Elsevier Inc. 89
Figure 2. Structural Basis for NBS Muta-
tions
(A) Trypsin degradation produces a stable hNbs1
folded core (hNbs1-fc, residues 1–334).
(B) Comparison of calculated SAXS curves for
hNbs1 models (red) with experimental scattering
(black) shows hNbs1-fc architecture closely
matches the S. pombe structure.
(C) Superposition of 12 homology hNbs1 models
with SAXS scattering c2 fits better than 1.3. ATM
phosphorylation sites in hNbs1 map to surface
accessible loops with observed conformational
variability between models. Ser278 phosphoryla-
tion could mediate autoregulatory BRCT peptide
binding in cis through an interaction with the phos-
phoprotein-binding cleft.
(D) Nbs1 657del5 frameshift mutation found in
90% of NBS patients generates protein fragments
p26 and p70. Sequence in red, resulting from
657del5, shows extra C-terminal residues added
to the N-terminal (p26) and C-terminal (p70) frag-
ments.
(E) A homology model for Arg215 in hNbs1 based
on the spNbs1-fc structure suggests that Arg215
forms a salt bridge from the BRCT linker to
a BRCT1 helix. R215W is predicted to disrupt
protein folding.
(F) The Nbs1 L150F missense mutation likely
disrupts the BRCT pSer-binding pocket. Leu150
is found in the hydrophobic core directly contact-
ing pSer ligands, based on the structure of a
BRCA1-phosphopeptide complex, RCSB ID
1T2V.
(G) Protease sensitivity of Nbs1 missense muta-
tions. Mutant R215W destabilizes the protein fold
whereas L150F shows wild-type resistance to
trypsin digestion.disconnect contributes to radio-sensitivity phenotypes and ulti-
mately to malignancies in NBS patients (Maser et al., 2001). At
the protein level, 657del5 causes molecular scission of hNbs1-
p95 into two halves: (1) an N-terminal (p26) fragment that fails
to interact with other members of the MRN complex and con-
tains the FHA-BRCT1 with an extended 15 amino acid C ter-
minus, and (2) a C-terminal (p70) fragment with intact Mre11-
ATM-binding motifs and an extended N-terminal peptide linked
to its BRCT2 domain (Figure 2D). Structurally, 657del5 physically
uncouples the Nbs1 FHA- and BRCT-mediated phosphoregula-
tory interactions of Nbs1 from its Mre11 and ATM/Tel1 interac-
tion regions. Besides split FHA and BRCT domains, we hypoth-
esize protein instability and decreased abundance of Nbs1-p70
underlying cancer incidence (Kruger et al., 2007) is caused by
solvent exposure of a large hydrophobic patch on BRCT2 that
normally forms the BRCT1-BRCT2 interface (Figure 2D).
Nbs1 Missense Mutations
Two missense mutations (R215W and L150F) mapping to Nbs1-
fc are linked to NBS (Seemanova et al., 2006) and breast cancer
(Heikkinen et al., 2006). The R215W (643C/T) mutation occurs90 Cell 139, 87–99, October 2, 2009 ª2009 Elsevier Inc.with 657del5 in compound heterozygous individuals with NBS
presenting unusually severe neurological abnormities (Seema-
nova et al., 2006). Arg215 lies in the BRCT1-BRCT2 linker region,
and salt bridges with Asp205 and Glu206 in our hNbs1-fc
homology models (Figure 2E). Mutation of hNbs1-fc Arg215 to
Trp confers trypsin sensitivity, suggesting that R215Wdecreases
Nbs1 protein stability (Figure 2G). Conversely, the L150F
breast cancer associated mutation displays no measurable
stability defect. However, L150Fflanks theNbs1BRCTphospho-
serine interaction cleft (Figure 2F). By analogy to BRCA1 muta-
tions occluding phosphoprotein-binding pockets, L150F may
deform thepSer-bindingpocket via a relayof hydrophobic distor-
tion (Williams et al., 2004).Whereas patientswithNbs1mutations
decreasing protein stability and abundance present with clas-
sical NBS symptoms, a specific linkage of Nbs1 L150F to breast
cancers may reflect critical functional roles for the Nbs1 BRCT
interactions in tumor suppression. Thus, Nbs1 disease-causing
mutations may either directly impact phosphoprotein binding
as seen for BRCA1 (Williams et al., 2004), or global protein
stability as seen for BRCA1 (Williams et al., 2001), XPD (Fan
et al., 2008), and superoxide dismutase (DiDonato et al., 2003).
Nbs1 Mutations in the FHA Phosphoprotein-Binding
Pocket Impair DSB Repair
hNbs1 binding to hMDC1 depends on both the FHA and BRCT
domains (Chapman and Jackson, 2008), probably via bipartite
Nbs1 FHA-BRCT interactions (Figure 1E, type iv binding).
Consensus phosphoprotein interaction motifs (Williams et al.,
2004) are missing in spNbs1 BRCT domains but present in
hNbs1 and higher eukaryotes (Figure S3). AsS. pombe also lacks
anMDC1ortholog, theNbs1FHAdomainmaymediate keyphos-
phorylation-dependent interactionswith otherDSB repair factors
through an FHA-only (Figure 1E, class i) interaction.
We addressed the functional importance of the FHA phospho-
protein-binding pocket in spNbs1. Arg27 and Lys45 are
conserved residues predicted to contact phosphothreonine
(pThr) in protein binding targets (Durocher et al., 1999), so we
constructed strains replacing one or both residues with alanine.
While neither single mutant is sensitive to DNA damage (except
at high doses for nbs1-R27A), the double mutant (nbs1-RKAA) is
sensitive to ionizing radiation (IR), the topoisomerase I poison
camptothecin (CPT), and the DNA replication inhibitor hydroxyr-
urea (HU) (Figure 3A). These mutations had no effect on Nbs1
abundance (Figure 3B).
Interestingly, nbs1-RKAA phenotypes matched those of nbs1
s10 (Figure 3A), a Gly103Asp mutant (Akamatsu et al., 2008) that
destabilizes the phosphoprotein-binding loop encompassing
Lys45 (Figure S6). Besides causing genotoxin sensitivity, nbs1
s10 has a synthetic lethal interaction with rad2D (Akamatsu
et al., 2008). Rad2 (FEN-1/RAD27) is a structure-specific endo-
nuclease that processes Okazaki fragments during DNA replica-
tion. Unprocessed Okazaki fragments lead to replication fork
collapse, causing damage that is repaired by an HR pathway
requiring MRN (Akamatsu et al., 2008). Further revealing the
importance of the Nbs1 FHA domain in mediating repair of
collapsed replication forks, nbs1-RKAA rad2D double mutants
are inviable (Figure 3C).
Nbs1 FHA Domain Mutations Disrupt
Nbs1-Ctp1 Interactions
The nbs1-RKAA and nbs1-s10 phenotypes suggest that Nbs1
FHA domain facilitates a phosphorylation-dependent interaction
with a key HR protein. As a high-copy suppressor of nbs1-s10
(Akamatsu et al., 2008), Ctp1 may interact with the Nbs1-FHA,
consistent with our finding that ctp1+ overexpression rescues
nbs1-RKAA (Figure 3D).
To test whether Nbs1 is required for Ctp1 localization to DSBs,
we used chromatin immunoprecipitation (ChIP) to measure
enrichment of Mre11, Nbs1 and Ctp1 at four sites 0.2–16 kb
away from a defined DSB created with HO endonuclease (Limbo
et al., 2007). We assayed gH2A as a marker enriched at regions
flanking a DSB, and we performed these assays in a mre11-
H134S mutant background (Williams et al., 2008), as ablated
Mre11 endonuclease activity increases ChIP signals for Mre11,
Nbs1 andCtp1 at DSBs, presumably because defective endonu-
clease processing of DNA ends increases MRN retention at a
DSB. Mre11-H134S, Nbs1, Ctp1, and gH2A were strongly en-
riched around the DSB in nbs1+ cells (Figure 3E). The gH2A
signal was weakest nearest the DSB (0.2 kb), while Ctp1 and
Nbs1 signals were strongest at this position. NoCtp1 enrichmentat the DSB was detected in nbs1D cells (Figure 3E), even though
Ctp1 abundance is unaffected by loss of Nbs1 (Akamatsu et al.,
2008). Mre11-H134S enrichment was unaffected in nbs1D cells
(Figure 3E). Truncated Nbs1 in nbs1-FHAD cells had a weak or
transient interaction with the DSB, but reduced abundance of
Nbs1-FHAD complicates interpretation of this result. Impor-
tantly, Ctp1 enrichment at the DSB was strongly impaired in
nbs1-DFHA cells. The same defect was seen in nbs1-RKAA
and nbs1-s10 mutants, yet the mutant Nbs1 proteins exhibit no
defect in associating with the DSB (Figure 3E). Quantitative
real-time PCR confirmed diminished recruitment of Ctp1 to the
DSB in the nbs1 mutants (Figure 3F).
Although we were previously unable to coprecipitate Ctp1 and
Nbs1 (Limbo et al., 2007), their mammalian counterparts asso-
ciate in vivo (Chen et al., 2008; Sartori et al., 2007). Indeed, by
adjusting cell extraction conditions and utilizing an mre11-
H134S background, we could detect Nbs1 in a Ctp1 immunopre-
cipitation when both proteins were expressed at endogenous
levels (Figure 3G). Importantly, nbs1-RKAAdisrupted this interac-
tion (Figure 3G). Collectively, these results reveal a critical role for
the Nbs1 FHA domain in mediating Ctp1 localization to DSBs.
Mutations in Ctp1 SXT Sites Disrupt
Interactions with Nbs1
To test whether Ctp1 phosphorylation is required for Nbs1
binding, we focused on potential casein kinase 2 (CK2) phos-
phorylation sites in Ctp1, as CK2 phosphorylates SDT sites in
hMDC1 that interact with the Nbs1 FHA in mammalian cells
(Chapman and Jackson, 2008; Melander et al., 2008; Spycher
et al., 2008; Wu et al., 2008). NetPhos 2.0 (http://www.cbs.dtu.
dk/services/NetPhos/) identified two clusters of probable CK2
sites in the Ctp1 N terminus: the first spanning Ser77, Thr78,
and Thr79, and the second containing Ser87 and Thr89
(Figure 4A). Based on their similarity to MDC1 SDT repeats, we
designated these clusters as SXT repeats. While mutation of
either SXT repeat had no noted effect on DNA damage sensi-
tivity, a mutant removing all Ser/Thr in the repeats (ctp1-5A)
was extremely damage sensitive, suggesting that the SXT
repeats are functionally redundant, not cooperative (Figure 4B).
The triple threonine mutant (ctp1-T78A T79A T89A) was as
DNA damage sensitive as ctp1-5A, while strains with paired
Ctp1 Thr-Ala substitutions (ctp1-T78A T89A or ctp1-T79A
T89A) are fully functional (Figure S7), so a single Thr within the
SXT repeats is sufficient for function. The ctp1-5A mutant grew
slowly, as is typical for Ctp1-defective strains (Limbo et al.,
2007), but did not reduce Ctp1 abundance or nuclear localization
(Figures 4C and 4D), indicating that Ctp1-5A is not grossly desta-
bilized or misfolded. ChIP analysis revealed a striking reduction
in Ctp1 enrichment at a DSB in the ctp1-5A mutant, as seen in
the nbs1-RKAA background (Figure 4E).
To test whether Ctp1 is phosphorylated on its SXT repeats, we
performed SDS-PAGE analyses of FLAG-tagged Ctp1 immuno-
precipitated from ctp1+ or ctp1-5A cells. In the absence of DNA
damage, Ctp1-5Amigrates faster thanwild-typeCtp1 (Figure 4F,
lanes 1 and 2), indicating that basal Ctp1 phosphorylation is
altered in thismutant. Consistent with this observation, phospha-
tase treatment causesbothwild-type andmutantCtp1 tomigrate
faster thaneither untreated sample, indicating thatCtp1 isbasallyCell 139, 87–99, October 2, 2009 ª2009 Elsevier Inc. 91
Figure 3. An Nbs1 FHA-Defective Mutant Causes DNA Damage Sensitivity and Decreases Ctp1 Localization to DSBs
(A) nbs1-RKAA (R27A K45A) cells are sensitive to DNA-damaging agents.
(B) Immunoblot of Nbs1-FLAG from strains used in (A). Expression of Nbs1-DFHA-FLAG is substantially decreased in soluble extracts relative to the wild-type.
Immunoblot with PSTAIR antisera recognizing Cdc2 is used as a loading control.
(C) Tetrad analysis of a cross between rad2D and nbs1-RKAA strains. The rad2D nbs1-RKAA double mutant is synthetic lethal, indicating a key role for the Nbs1
FHA domain in recombination-dependent DNA repair.
(D) Ctp1 is a multicopy suppressor of DNA damage sensitivity observed in the nbs1-RKAA mutant.92 Cell 139, 87–99, October 2, 2009 ª2009 Elsevier Inc.
phosphorylated on SXT repeats and other sites (Figure 4F, lanes
5 and 6). Exposure to the radiomimetic drug bleomycin induces
further Ctp1 phosphorylation that results in a shift to slower
mobility, but this shift is ablated in Ctp1-5A (Figure 4F, lanes 3
and 4). This DNA damage-induced hyperphosphorylation of
Ctp1 requires Mre11, Nbs1 and either of the ATM/ATR-like
kinases (Tel1/Rad3) in fission yeast (Akamatsu et al., 2008).
To test whether the SXT repeats in Ctp1 mediate direct inter-
actions with the FHA domain of Nbs1, we monitored in vitro
association of Nbs1-fc with phosphorylated Ctp1 peptides by
size exclusion chromatography (Figure 5). Nbs1-fc directly binds
and coelutes with phosphorylated fluorescein (FITC)-conjugated
Ctp1 peptides encompassing either of the functionally redun-
dant SXT repeats. These interactions were phosphorylation-
dependent and reduced by the nbs1-RKAA mutation.
(E) ChIP analysis of gH2A, Mre11-H134S, Nbs1, and Ctp1 around a DSB created by HO endonuclease expressed from thiamine-repressible nmt1 promoter.
Samples were collected at indicated times after depletion of thiamine from medium. Ctp1 localization at 0.2 kb from the DSB is defective in the nbs1 mutants.
(F) Quantitative real-time PCR was used to measure enrichment of Ctp1 at 0.2 kb from the HO endonuclease-induced DSB.
(G) Ctp1 associates with Nbs1 in an FHA domain-dependent manner. Strains were generated that express TAP-tagged Ctp1 and FLAG-tagged Nbs1 in an
mre11-H134S background. IgG Sepharose beads were used to precipitate TAP-tagged Ctp1 and any associated proteins (negative control is a strain lacking
Ctp1-TAP).
Figure 4. Phosphorylation Motif Required
for Ctp1 Activity
(A) Ctp1 schematic depicting conserved N-
terminal coiled coil domain (CC), C-terminal core
homology region (CXXC/RHR), and putative phos-
phorylation motif (SXT). Motif enlargement shows
residue substitutions in the ctp1-3A, ctp1-2A,
and ctp1-5A strains.
(B) ctp1-5A cells are sensitive to exogenous DNA-
damaging agents, similar to ctp1D cells.
(C) Ctp1-TAP immunoblot from strains used in (B),
showing that Ctp1mutants are expressed at levels
at or above the wild-type amount (PSTAIR immu-
noblot loading control).
(D) GFP-Ctp1-5A intracellular localization is unal-
tered relative to GFP-Ctp1-wt.
(E) ChIP analysis of Ctp1 enrichment surrounding
an HO endonuclease-induced DSB. Samples
were collected at the indicated time after HO-
induction. Ctp1 fails to localize to a site 0.2 kb
from the DSB in the nbs1-RKAA and ctp1-5A
strains.
(F) Basal phosphorylation is altered and damage-
induced phosphorylation is abrogated in Ctp1-5A
relative to the wild-type. In asynchronous cells,
Ctp1 is phosphorylated basally (Ctp1-FLAG-P),
shown by increased Ctp1 mobility (Ctp1-FLAG)
after lPPase treatment. After exposure to bleomy-
cin, Ctp1 is hyperphosphorylated, causing a
decrease in mobility (Ctp1-FLAG-PP) relative to
the basally phosphorylated form.
Nbs1-Ctp1 Complex Structure
To define Nbs1-Ctp1 interactions, we
cocrystallized and determined the 2.15
A˚ resolution X-ray structure of the first
Ctp1 SXT repeat bound to Nbs1-fc (Table
S2, Figures 6 and S8). FITC-Ctp1 phos-
phopeptides enabled us to visually identify yellow Nbs1-fc-
Ctp1 complex crystals in a background of peptide-free Nbs1-fc
crystals (Figure 6B, Experimental Procedures). Phosphorylated
Ctp1 binds in an electropositive groove formed by FHA residues
Arg27, Lys45, Phe77, Lys76, Lys104, Ser44, and Lys41 (Fig-
ure 6C), and buries 644 A˚2 of solvent accessible surface at
the Ctp1-Nbs1 interface. Ctp1 Ile72 - pSer77 and residues
C-terminal to Glu81 (Asp82 and Glu83) are disordered. In
contrast, 2Fo-Fc and Fo-Fc difference maps show electron
density for Ctp1 pThr79, positions pThr(1) (Thr78) through
pThr(+2) (Glu81), and pSer77 main chain, but not the pSer phos-
phate (Figure S8), underscoring the importance of these residues
for Nbs1 binding.
The Nbs1 peptide-binding groove interacts with Ctp1 on three
sides (Figures 6C and 6D) and significant rearrangements of theCell 139, 87–99, October 2, 2009 ª2009 Elsevier Inc. 93
Figure 5. Nbs1 FHA Domain Binds Phosphorylated Ctp1
(A) Analytical gel filtration binding analyses of Nbs1-Ctp1 protein-phosphopeptide interactions. Coelution of FITC-labeled Ctp1 peptides (see sequence insets)
absorbing at 495 nm (red trace) with recombinant Nbs1-fc variants (black A280 trace) monitors binding.
(B) Fluorescence polarization binding analyses of Nbs1-Ctp1 peptides.interacting loops occur as they ‘‘grasp’’ Ctp1 (Movies S1 and
S2). The pThr79 phosphate directly contacts the side chains of
Arg27, Ser44, and Lys45. Residues Arg27, Lys45, Ser42, Ile43,
Lys76, Ser44, and a tightly bound water molecule mold the
pThr interaction site surface (Figure 6D). This pocket appears
to specifically bind pThr preferentially over pSer or pTyr: it is
too small for pTyr binding and tightly contours around the
pThr79 side chain methyl. Redundant contacts by Arg27 and
Lys45 with the pThr phosphate explain the mild phenotypes
observed for nbs1-R27A and nbs1-K45A single mutants as
compared to the nbs1-RKAA double mutant (Figure 3A).
Our structure of the Nbs1-Ctp1 complex, conservation of the
Nbs1 FHA phosphopeptide-binding cleft, and homology of the
Ctp1 SXT repeats to Nbs1-binding motifs in human MDC1
(Chapman and Jackson, 2008; Melander et al., 2008; Spycher
et al., 2008) and S. cerevisiae Lif1 (Palmbos et al., 2008) together
define an Nbs1 FHA-binding consensus sequence motif as
a pThr with an Asp at position pThr(+1) (Figures 6D and 6E).
Conserved residues Lys76 and Phe77, along with Lys41 and
Lys104 recognize Ctp1 Asp80 [pThr (+1)]. Conversely, recogni-94 Cell 139, 87–99, October 2, 2009 ª2009 Elsevier Inc.tion of Ctp1 Glu81 [pThr(+2)] by Nbs1 Lys104 appears specific
to the S. pombe Nbs1-Ctp1 interaction. While Phe77 makes
van der Waals contacts to the peptide backbone, Lys76
hydrogen bonds to the pThr79 main chain carbonyl and
combines with Lys41 in salt bridges that sandwich the acidic
pThr(+1) specificity position (Asp80). Consistent with structural
observations, an Nbs1 mutant (Ala76-Ala77) impairs Ctp1
peptide binding, showing the conserved Lys76-Phe77 loop is
crucial for the interaction (Figure 5A).
Whereas most FHA domains recognize pThr(+3) position,
specific interactions with Nbs1-FHA in cells are probably
achieved by unique recognition of pThr-Aspmotifs. Added spec-
ificity for the CtIP-MRN complex interaction in complex eukary-
otes may also occur via avidity, as CtIP also binds Mre11 and
Rad50 (Sartori et al., 2007). Conservation of acidic residues
C-terminal to pThr(+2) and phosphorylation at pSer(2) could
reflect kinase recognition specificity for efficient in vivo phos-
phorylation, rather than a preferred Nbs1-FHA-binding con-
sensus (Figure 6E), as a single or double phosphorylated Ctp1
peptide binds Nbs1-fc with similar affinity (Figure 5B).
Use of a minimalist pThr-Asp Nbs1-FHA interaction con-
sensus binding motif may direct MRN binding to multiple cellular
targets. We predict the Xrs2Nbs1-Lif1 interaction facilitating
MRN(X) DSB repair by nonhomologous end joining in budding
yeast (Palmbos et al., 2008) assembles via interactions between
Figure 6. Nbs1-Ctp1 Complex
(A) Overall structure. Ctp1 binds Nbs1 in a surface groove at the distal
N-terminal FHA domain. Bound Ctp1 phosphopeptide (orange) is overlaid
upon the Nbs1 surface.
(B) Left, crystals of the Nbs1-Ctp1 complex (yellow) grow in a background of
colorless free Nbs1-fc crystals. Right, Nbs1:Ctp1 cocrystal used for structure
determination.
(C) Nbs1 FHA domain forms a positively charged groove (blue electrostatic
potential) for binding Ctp1 acidic residues pThr79 and Asp80 [pThr(+1)] and
Glu81 [pThr(+2)] in an extended conformation. Ctp1 (orange) is displayed over-
laid upon an electrostatic surface representation of the Nbs1 peptide-binding
surface.
(D) Nbs1-Ctp1 interaction details.
(E) Sequence alignment of Nbs1 interaction proteins shows key specificity.
(F) Schematic of known Nbs1 protein-phosphoprotein interactions regulating
NHEJ, DSB signaling and HR repair. Residues with white and red phosphates
are predicted to be key for Nbs1 interactions in the FHA or BRCT-BRCT phos-
phoprotein-binding clefts, whereas gray residues and phosphates in the
consensus are predicted to not make direct Nbs1 contacts.the Xrs2Nbs1-FHA domain and Lif1 CK2 phosphoacceptor sites
analogous to the Ctp1 SXT repeats (Figures 6E and 6F). By
contrast, mammalian Nbs1 binding to clusters of MDC1 SDTD
repeats depends on both FHA and BRCT phosphoprotein inter-
action sites and phosphorylation of the serine and threonine in
the SDTD motif (Chapman and Jackson, 2008; Melander et al.,
2008; Spycher et al., 2008). As BRCT domains typically bind
pSer targets with specificity for the pSer(+3) position (Glover
et al., 2004; Manke et al., 2003), our data predict that Nbs1-
MDC1 complexes assemble through a bipartite interaction
between the Nbs1 FHA domain binding the pTD of an MDC1
SDTD motif and the Nbs1 BRCT domains recognizing a neigh-
boring MDC1 pSXXD consensus of a second SDTD repeat
(Figures 6E and 6F).
Nbs1 Is an Extended Flexible Interaction Hub
Nbs1 might provide rigid architectures to align its multiple inter-
action partners. Yet, Nbs1 proteolytic lability suggests that its C
terminus is disordered (Figure 1B). To test these possibilities, we
examined spNbs1-fc and spNbs1-DAT structures in solution
with SAXS (Hura et al., 2009). While spNbs1-fc SAXS closely
matches the X-ray structure, the maximum particle dimension
(Dmax) for spNbs1-DAT is much larger (175 A˚), indicating
a very elongated structure (Figures 7A and 7B). SAXS objectively
measures folding: Kratky plots are parabolic for folded struc-
tures, asymptotic for unfolded structures, and intermediate for
partially folded structures (Putnam et al., 2007). Consistent
with an unstructured Nbs1 C terminus, the spNbs1-DAT Kratky
plot is intermediate between parabolic and asymptotic curves,
while spNbs1-fc has a parabolic plot showing spNbs1-fc is
folded consistent with proteolysis and crystal structures
(Figure 7C).
Although its C terminus may undergo disorder-to-order transi-
tions upon binding Mre11 and ATM, we do not see stable
domains (>10 kDa) when Nbs1 is trypsin digested while in
complex with Mre11 (Figure S9). Thus, C-terminal Mre11 and
ATM interacting regions may be peptide interaction motifs,
rather than globular domains. Sequence-based order predic-
tions of Nbs1 homologs (Figures 7D and S10) suggest that flex-
ibility is a conserved Nbs1 feature, so inherent pliability of the
Nbs1 C terminus may be needed for function. Furthermore, flex-
ibility extends into Nbs1-fc: the closed, phosphopeptide
grasped FHA conformation flips an Arg switch at the FHA-
BRCT interface and promotes conformational changes in the
BRCT linker region, an 20 rotation about the BRCT1-BRCT2
interface, and an 10 A˚ shift at the BRCT2 C-terminal end in
our experimentally determined X-ray structures (Figure 7E).
DISCUSSION
Nbs1 provides the key phosphoprotein sensor and recruitment
scaffold for the Mre11-Rad50 complex. Our SAXS analysis,
proteolysis and X-ray structure determinations reveal that
Nbs1 contains a folded N-terminal FHA-BRCT1-BRCT2 core,
conserved from S. pombe to humans based upon the SAXS
results, that uniquely connects an FHA phosphoprotein-binding
site with BRCT domains via an extensive interface. Our genetic
and biochemical studies, combined with the structural analysisCell 139, 87–99, October 2, 2009 ª2009 Elsevier Inc. 95
of an Nbs1-Ctp1 complex, establish that the Nbs1 FHA domain
binds phosphorylated motifs in Ctp1, and in doing so recruits
Ctp1 to DSBs. This interaction is critical for DNA repair in fission
Figure 7. Nbs1 Is an Extended, Flexible,
Effector, and Signaling Scaffold
(A) spNbs1-fc (1–329) (blue) and spNbs1-DAT (1–
553) (black) proteins were characterized by SAXS.
(B) SAXS electron pair distribution function shows
spNbs1DAT is elongated in solution.
(C) SAXS Kratky plot indicates spNbs1DAT is only
partially folded in solution.
(D) S. pombe Nbs1 order-disorder predictions
from IUPRED. Predicted ordered (blue bars) and
unstructured regions (no blue bars) shows
stretches of disorder tendency >0.5.
(E) Structural overlay of Ctp1-bound (brown) and
apo-Nbs1 (blue) crystal forms shows BRCT1-
BRCT2 interface rotation and helical rearrange-
ments at the FHA-BRCT1 interface. Left inset, an
FHA domain arginine switch (R16) toggles
between two conformational states, directly link-
ing the FHA motions to the BRCT domains.
(F) Model of MRN-Ctp1 complex bound at
a bridging DNA DSB. The flexible Nbs1 C terminus
links FHA-bound Ctp1 to an Mre11-Rad50 hetero-
tetrameric core complex bridging a DNA double-
strand break.
yeast. These data largely agree with the
independent findings of Lloyd et al.
(2009), who in this issue of Cell report
their structural and functional studies
linking Nbs1 and Ctp1 in S. pombe.
The direct fusion of two phosphopro-
tein-binding domains in Nbs1 implies
that functional crosstalk between binding
sites may occur. Interestingly, structural
overlays of the apo and peptide-bound
crystal structures reveal an Nbs1-fc
conformational change that may facilitate
FHA-BRCT phosphoprotein-binding site
communication and pull on the flexible
tether to Mre11 (Figure 7E, Movies S3
and S4).
Integrating our results with known data
supports a testable architectural hypoth-
esis forMRN-Ctp1 (Figure 7F).MRNcom-
plex components and Ctp1 colocalize to
within 200 bp (<700 A˚), of a defined
endonuclease cut DSB in vivo (Figure 3E).
Ctp1 is retained at the break site via direct
phosphorylation-dependent binding to
the N-terminal Nbs1 FHA domain. SAXS
and X-ray structures define the reach
from the Nbs1 C-terminal Mre11
interaction region to the N-terminal FHA
domain as 175 A˚. Prior results also
help delineate MRN-Ctp1 complex archi-
tecture at a DSB: (1) the Mre11-Rad50
DNA-binding head can directly bind and bridge DNA ends
(Chen et al., 2001;Williams et al., 2008), (2) theMre11/Rad50 het-
erotetrameric core forms a four-lobed DNA-binding head96 Cell 139, 87–99, October 2, 2009 ª2009 Elsevier Inc.
composed of dimeric Mre11 and the Rad50 ATPase domains,
with Rad50 coiled-coils emanating from the head (Hopfner
et al., 2001, 2002), and (3) the Mre11-Nbs1-binding interface
maps to Nbs1 C-terminal motifs (Falck et al., 2005; You et al.,
2005) and an Mre11 dimer surface patch away from the DNA-
binding cleft (Williams et al., 2008). Rad50 coiled-coils are posi-
tioned to define the reach of the MRN complex to bridge homol-
ogous sister chromatids during HR repair (Hopfner et al., 2002;
Moreno-Herrero et al., 2005). Direct synapsis of DNA ends by
Mre11 (Williams et al., 2008), and the tethering length of the
Nbs1 connection between Ctp1 andMre11 defined here support
a mechanism for localizing both the MRN complex and Nbs1-
linkedCtp1 to regions directly flanking aDSB (Figure 7F). Consis-
tentwith this composite structuralmodel, archaealMre11/Rad50
core complex (Hopkins and Paull, 2008) or eukaryotic MRN/
Ctp1Sae2 50-30 resection activity is limited to regions proximal to
a DSB (Mimitou and Symington, 2008; Zhu et al., 2008).
Flexible Nbs1 molecular associations may accommodate
large-scale MRN complex conformational changes, proposed
to regulate ATM activation and dimer-to-monomer transitions
(Lee and Paull, 2005). Like the flexible linkage of PCNA to ligase
for DNA replication (Pascal et al., 2006), the malleable nature of
Nbs1 and the Rad50 coils (Moreno-Herrero et al., 2005) provides
a molecular basis for concerted MRN DNA break sensing and
repair activities while preserving the integrity of a structurally
dynamic chromatin template. With its apex FHA-binding motif
and conformational switch encompassing the FHA-BRCT inter-
face, the mobile Nbs1 hub appears suitable to promote integra-
tion of repair sensing and effector activities of MRN by interface
exchange and handoff interactions with multiple partners, as
proposed for PCNA (Chapados et al., 2004) and BRCA2-
Rad51 partners (Shin et al., 2003).
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
Recombinant S. pombe and human Nbs1 variants were expressed from
pET29b as C-terminal 6-His tagged proteins in E. coliRosetta2 (DE3) cells (No-
vagen) grown at 16C in Terrific Broth. After Ni-NTA affinity chromatography,
proteins were purified by Superdex 75 (GE Healthcare) (spNbs1-fc:1-329,
hNbs1-fc:1-334, and hNbs1:1-392) or Superdex 200 (spNbs1-DAT, residues
1–553) gel filtration, and anion exchange chromatography. S. pombe Nbs1-fc
mutants (G103D, R27A/K45A, and K76A/F77A) and hNbs1-fcmutants (R215W
and L150F) were made with Quickchange (Stratagene).
Nbs1-fc Crystallization
spNbs1-fccrystalsweregrownat8Cbyhanging-dropvapordiffusion.Nbs1-fc
crystals were grown by mixing 1 ml protein solution (10 mg/ml spNbs1-fc in
500 mM NaCl, 20 mM Tris-HCl [pH 7.5], 0.1% b-mercaptoethanol) and 1mL
crystallization solution A (2 M NaCl, 100 mM sodium acetate [pH 5.5]). Plate
morphology was improved with crush dilution seeding into drops with 1 ml
crystallizationsolutionB (1.2-1.4Mpotassium formate, 100mMsodiumacetate
[pH 4.6], 5% w/v polyethylene glycol 8000) and 1 ml protein solution. For data
collection, crystals were transferred to cryoprotectant (crystallization solution
B plus 26% ethylene glycol) and flash cooled in liquid nitrogen.
Nbs1-Ctp1 Complex Crystallization
Peptides were synthesized at the Scripps Research Institute core facility.
Colorless peptide-free and yellow peptide-bound (FITC-conjugated) crystals
grew in the same drop. Ten milligrams per milliliter spNbs1-fc in 40 mM
NaCl, 20 mM Tris 7.5, 0.1% b-mercaptoethanol was mixed with FITC-Ctp1-1[FITC-KKIQELD(pS)T(pT)DEDEI-nh2] at a 4:1 Ctp1-1/spNbs1-fc ratio. Crystals
were grown at 8C by hanging-drop vapor diffusion by mixing 1 ml Nbs1-Ctp1
complex with 1 ml crystallization solution C (18% Polyethylene glycol 3350,
100 mM MES [pH 6.1–6.5], 260 mM potassium thiocyanate). Crystals were
washed in cryoprotectant (crystallization solution C with 26% glycerol), and
yellow peptide-containing crystals were flash cooled in liquid nitrogen for
data collection.
X-Ray Diffraction Data Collection Phasing and Processing
Data processing, phasing, model building, and refinement are detailed in
the Supplemental Data. Final refined models of apo Nbs1 at 2.8 A˚ resolution
(R = 23.6, Rfree = 28.5) and Nbs1/Ctp1 complex at 2.2 A˚ resolution (R = 21.5,
Rfree = 26.42) exhibit excellent geometry (Table S2).
Peptide Binding Studies
FITC-conjugated peptide binding to Nbs1-fc variants was monitored by
coelution in gel filtration or fluorescence polarization for sample concentra-
tions detailed in the Supplemental Data.
Small Angle X-Ray Scattering Data Collection and Processing
SAXS data were collected at SIBYLS beamline 12.3.1 at the Advanced Light
Source, Lawrence Berkeley National Laboratory. SAXS scattering data was
collected for 2.5, 5.0, and 10.0 mg/ml samples for Nbs1-fc, 2 mg/ml samples
of spNbs1-DAT, and 10 mg/ml hNbs1-fc. SAXS analysis was done as
described in the Supplemental Data.
Strain Construction
Strains used are listed in Table S1.
Antibodies and Western Blotting
a-PAP, a-FLAG, and a-PSTAIR antibodies (Sigma) were used for western blot-
ting of whole-cell extracts or immunoprecipitates as described (Akamatsu
et al., 2008; Limbo et al., 2007).
Cell Extract Preparation
Exponentially growing cells were exposed to bleomycin as described (Aka-
matsu et al., 2008). Whole-cell extracts were prepared by disruption in lysis
buffer (50 mM Tris [pH 8.0], 150 mM NaCl, 2.5 mM EDTA, 0.002% NP-40,
50 mM NaF, protease inhibitor tablet [Roche, complete Mini]) with a bead
beater.
HO Endonuclease ChIP Assay and Real-Time PCR
Chromatin immunoprecipitation assays were done as described (Limbo et al.,
2007) with strains detailed in the Supplemental Data.
Nbs1-Ctp1 Coimmunoprecipitation
Soluble whole-cell extracts were made from exponentially growing cells by
disrupting in low-salt lysis buffer B1 (50 mM Tris [pH 8.0], 50 mM NaCl,
2.5 mM EDTA, 0.002% NP-40, 50 mM NaF, protease inhibitor tablet [Roche,
complete Mini]) with a bead beater. Ctp1-TAP and associated proteins were
precipitated from extracts with a 50% suspension of IgG Sepharose (GE
Healthcare), washed three times with B1 buffer, resolved on 8% SDS-PAGE,
and examined by western blotting.
Fluorescence Microscopy
Ctp1 complementary DNA was cloned as N-terminal GFP fusion proteins
under control of the thiamine-repressible nmt1 promoter (pREP41). Cells
were then grown in the absence of thiamine for 20 hr to induce GFP-Ctp1
expression. Images were collected as described (Limbo et al., 2007).
Ctp1 Phosphorylation Assay
Ctp1-FLAG immunoprecipitation from whole-cell extracts and subsequent
lPPase treatment of precipitates were done as described (Akamatsu et al.,
2008).Cell 139, 87–99, October 2, 2009 ª2009 Elsevier Inc. 97
ACCESSION NUMBERS
Coordinates and structure factors for Nbs1-fc (RCSB accession code 3HUE)
and the Nbs1-fc/Ctp1 complex (RCSB accession code 3HUF) are in the
Protein Data Bank.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, ten
figures, two tables, and two movies and can be found with this article online
at http://www.cell.com/supplemental/S0092-8674(09)00913-1.
ACKNOWLEDGMENTS
Fellowship support was provided to R.S.W. (Canadian Institutes of Health
Research, the Alberta Heritage Foundation for Medical Research, and the
Skaggs Institute for Chemical Biology), G.E.D. (National Institutes of Health
National Research Service Award), and Y.Y. (The Uehara Memorial Founda-
tion). Work on Mre11 complex and Ctp1 in the authors’ laboratories is
supported by National Cancer Institute grants CA117638, CA92584, and
CA77325. SIBYLS beamline (BL12.3.1) efforts at the Advanced Light Source
of Lawrence Berkeley National Laboratory are supported by United States
Department of Energy program Integrated Diffraction Analysis Technologies
(for integrating crystallography and X-ray scattering) under contract number
DE-AC02-05CH11231. We thank SIBYLS staff G. Hura and M. Hammel for
expert SAXS data collection assistance, B. Chapados, C. Chahwan for discus-
sions, and E. Getzoff and G. Williams for comments.
Received: February 25, 2009
Revised: May 14, 2009
Accepted: July 10, 2009
Published: October 1, 2009
REFERENCES
Akamatsu, Y., Murayama, Y., Yamada, T., Nakazaki, T., Tsutsui, Y., Ohta, K.,
and Iwasaki, H. (2008). Molecular characterization of the role of the Schizosac-
charomyces pombe nip1+/ctp1+ gene in DNA double-strand break repair in
association with the Mre11-Rad50-Nbs1 complex. Mol. Cell. Biol. 28,
3639–3651.
Bernstein, N.K., Williams, R.S., Rakovszky, M.L., Cui, D., Green, R., Karimi-
Busheri, F., Mani, R.S., Galicia, S., Koch, C.A., Cass, C.E., et al. (2005). The
molecular architecture of the mammalian DNA repair enzyme, polynucleotide
kinase. Mol. Cell 17, 657–670.
Carney, J.P., Maser, R.S., Olivares, H., Davis, E.M., Le Beau, M., Yates, J.R.,
3rd, Hays, L., Morgan, W.F., and Petrini, J.H. (1998). The hMre11/hRad50
protein complex and Nijmegen breakage syndrome: linkage of double-strand
break repair to the cellular DNA damage response. Cell 93, 477–486.
Chapados, B.R., Hosfield, D.J., Han, S., Qiu, J., Yelent, B., Shen, B., and
Tainer, J.A. (2004). Structural basis for FEN-1 substrate specificity and
PCNA-mediated activation in DNA replication and repair. Cell 116, 39–50.
Chapman, J.R., and Jackson, S.P. (2008). Phospho-dependent interactions
between NBS1 and MDC1 mediate chromatin retention of the MRN complex
at sites of DNA damage. EMBO Rep. 9, 795–801.
Chen, L., Trujillo, K., Ramos,W., Sung, P., and Tomkinson, A.E. (2001). Promo-
tion of Dnl4-catalyzed DNA end-joining by the Rad50/Mre11/Xrs2 and Hdf1/
Hdf2 complexes. Mol. Cell 8, 1105–1115.
Chen, L., Nievera, C.J., Lee, A.Y., and Wu, X. (2008). Cell cycle-dependent
complex formation of BRCA1.CtIP.MRN is important for DNA double-strand
break repair. J. Biol. Chem. 283, 7713–7720.
Chen, P.L., Liu, F., Cai, S., Lin, X., Li, A., Chen, Y., Gu, B., Lee, E.Y., and Lee,
W.H. (2005). Inactivation of CtIP leads to early embryonic lethality mediated by
G1 restraint and to tumorigenesis by haploid insufficiency. Mol. Cell. Biol. 25,
3535–3542.98 Cell 139, 87–99, October 2, 2009 ª2009 Elsevier Inc.Clapperton, J.A., Manke, I.A., Lowery, D.M., Ho, T., Haire, L.F., Yaffe, M.B.,
and Smerdon, S.J. (2004). Structure and mechanism of BRCA1 BRCT domain
recognition of phosphorylated BACH1 with implications for cancer. Nat.
Struct. Mol. Biol. 11, 512–518.
DiDonato, M., Craig, L., Huff, M.E., Thayer, M.M., Cardoso, R.M., Kassmann,
C.J., Lo, T.P., Bruns, C.K., Powers, E.T., Kelly, J.W., et al. (2003). ALS mutants
of human superoxide dismutase form fibrous aggregates via framework desta-
bilization. J. Mol. Biol. 332, 601–615.
Difilippantonio, S., Celeste, A., Fernandez-Capetillo, O., Chen, H.T., Reina San
Martin, B., Van Laethem, F., Yang, Y.P., Petukhova, G.V., Eckhaus, M.,
Feigenbaum, L., et al. (2005). Role of Nbs1 in the activation of the Atm kinase
revealed in humanized mouse models. Nat. Cell Biol. 7, 675–685.
Digweed, M., and Sperling, K. (2004). Nijmegen breakage syndrome: clinical
manifestation of defective response to DNA double-strand breaks. DNA
Repair (Amst.) 3, 1207–1217.
Durocher, D., Henckel, J., Fersht, A.R., and Jackson, S.P. (1999). The FHA
domain is a modular phosphopeptide recognition motif. Mol. Cell 4, 387–394.
Falck, J., Coates, J., and Jackson, S.P. (2005). Conserved modes of recruit-
ment of ATM, ATR and DNA-PKcs to sites of DNA damage. Nature 434,
605–611.
Fan, L., Fuss, J.O., Cheng, Q.J., Arvai, A.S., Hammel, M., Roberts, V.A.,
Cooper, P.K., and Tainer, J.A. (2008). XPD helicase structures and activities:
insights into the cancer and aging phenotypes from XPD mutations. Cell
133, 789–800.
Glover, J.N., Williams, R.S., and Lee, M.S. (2004). Interactions between BRCT
repeats and phosphoproteins: tangled up in two. Trends Biochem. Sci. 29,
579–585.
Goldberg, M., Stucki, M., Falck, J., D’Amours, D., Rahman, D., Pappin, D.,
Bartek, J., and Jackson, S.P. (2003). MDC1 is required for the intra-S-phase
DNA damage checkpoint. Nature 421, 952–956.
Hartsuiker, E., Neale, M.J., and Carr, A.M. (2009). Distinct requirements for the
Rad32(Mre11) nuclease and Ctp1(CtIP) in the removal of covalently bound
topoisomerase I and II from DNA. Mol. Cell 33, 117–123.
Heikkinen, K., Rapakko, K., Karppinen, S.M., Erkko, H., Knuutila, S., Lundan,
T., Mannermaa, A., Borresen-Dale, A.L., Borg, A., Barkardottir, R.B., et al.
(2006). RAD50 and NBS1 are breast cancer susceptibility genes associated
with genomic instability. Carcinogenesis 27, 1593–1599.
Hopfner, K.P., Karcher, A., Shin, D.S., Craig, L., Arthur, L.M., Carney, J.P., and
Tainer, J.A. (2000). Structural biology of Rad50 ATPase: ATP-driven conforma-
tional control in DNA double-strand break repair and the ABC-ATPase super-
family. Cell 101, 789–800.
Hopfner, K.P., Karcher, A., Craig, L., Woo, T.T., Carney, J.P., and Tainer, J.A.
(2001). Structural biochemistry and interaction architecture of the DNAdouble-
strand break repair Mre11 nuclease and Rad50-ATPase. Cell 105, 473–485.
Hopfner, K.P., Craig, L., Moncalian, G., Zinkel, R.A., Usui, T., Owen, B.A.,
Karcher, A., Henderson, B., Bodmer, J.L., McMurray, C.T., et al. (2002). The
Rad50 zinc-hook is a structure joining Mre11 complexes in DNA recombina-
tion and repair. Nature 418, 562–566.
Hopkins, B.B., and Paull, T.T. (2008). The P. furiosus Mre11/Rad50 complex
promotes 50 strand resection at a DNA double-strand break. Cell 135,
250–260.
Hura, G.L., Menon, A.L., Hammel, M., Rambo, R.P., Poole, F.L., 2nd,
Tsutakawa, S.E., Jenney, F.E., Jr., Classen, S., Frankel, K.A., Hopkins, R.C.,
et al. (2009). Robust, high-throughput solution structural analyses by small
angle X-ray scattering (SAXS). Nat. Methods 6, 606–612.
Kruger, L., Demuth, I., Neitzel, H., Varon, R., Sperling, K., Chrzanowska, K.H.,
Seemanova, E., and Digweed, M. (2007). Cancer incidence in Nijmegen
breakage syndrome is modulated by the amount of a variant NBS protein.
Carcinogenesis 28, 107–111.
Lee, J.H., and Paull, T.T. (2005). ATM activation by DNA double-strand breaks
through the Mre11-Rad50-Nbs1 complex. Science 308, 551–554.
Lengsfeld, B.M., Rattray, A.J., Bhaskara, V., Ghirlando, R., and Paull, T.T.
(2007). Sae2 is an endonuclease that processes hairpin DNA cooperatively
with the Mre11/Rad50/Xrs2 complex. Mol. Cell 28, 638–651.
Limbo, O., Chahwan, C., Yamada, Y., de Bruin, R.A., Wittenberg, C., and
Russell, P. (2007). Ctp1 is a cell-cycle-regulated protein that functions with
Mre11 complex to control double-strand break repair by homologous recom-
bination. Mol. Cell 28, 134–146.
Lloyd, J., Chapman, J.R., Clapperton, J.A., Haire, L.F., Hartsuiker, E., Li, J.,
Carr, A.M., Jackson, S.P., and Smerdon, S.J. (2009). A supramodular FHA/
BRCT-repeat architecture mediates Nbs1 adaptor function in response to
DNA damage. Cell 139, this issue, 100–111.
Lou, Z., Minter-Dykhouse, K., Franco, S., Gostissa, M., Rivera, M.A., Celeste,
A., Manis, J.P., van Deursen, J., Nussenzweig, A., Paull, T.T., et al. (2006).
MDC1 maintains genomic stability by participating in the amplification of
ATM-dependent DNA damage signals. Mol. Cell 21, 187–200.
Manke, I.A., Lowery, D.M., Nguyen, A., and Yaffe, M.B. (2003). BRCT repeats
as phosphopeptide-binding modules involved in protein targeting. Science
302, 636–639.
Maser, R.S., Zinkel, R., and Petrini, J.H. (2001). An alternative mode of trans-
lation permits production of a variant NBS1 protein from the common Nijme-
gen breakage syndrome allele. Nat. Genet. 27, 417–421.
Melander, F., Bekker-Jensen, S., Falck, J., Bartek, J., Mailand, N., and Lukas,
J. (2008). Phosphorylation of SDT repeats in the MDC1 N terminus triggers
retention of NBS1 at the DNA damage-modified chromatin. J. Cell Biol. 181,
213–226.
Mimitou, E.P., and Symington, L.S. (2008). Sae2, Exo1 and Sgs1 collaborate in
DNA double-strand break processing. Nature 455, 770–774.
Moreno-Herrero, F., de Jager, M., Dekker, N.H., Kanaar, R., Wyman, C., and
Dekker, C. (2005). Mesoscale conformational changes in the DNA-repair
complex Rad50/Mre11/Nbs1 upon binding DNA. Nature 437, 440–443.
Neale, M.J., Pan, J., and Keeney, S. (2005). Endonucleolytic processing of
covalent protein-linked DNA double-strand breaks. Nature 436, 1053–1057.
Palmbos, P.L., Wu, D., Daley, J.M., and Wilson, T.E. (2008). Recruitment of
Saccharomyces cerevisiae Dnl4-Lif1 complex to a double-strand break
requires Interactions With Yku80 and the Xrs2 FHA domain. Genetics 180,
1809–1819.
Pascal, J.M., Tsodikov, O.V., Hura, G.L., Song, W., Cotner, E.A., Classen, S.,
Tomkinson, A.E., Tainer, J.A., and Ellenberger, T. (2006). A flexible interface
between DNA ligase and PCNA supports conformational switching and
efficient ligation of DNA. Mol. Cell 24, 279–291.
Putnam, C.D., Hammel, M., Hura, G.L., and Tainer, J.A. (2007). X-ray solution
scattering (SAXS) combined with crystallography and computation: defining
accurate macromolecular structures, conformations and assemblies in solu-
tion. Q. Rev. Biophys. 40, 191–285.
Sartori, A.A., Lukas, C., Coates, J., Mistrik, M., Fu, S., Bartek, J., Baer, R.,
Lukas, J., and Jackson, S.P. (2007). HumanCtIP promotes DNA end resection.
Nature 450, 509–514.Seemanova, E., Sperling, K., Neitzel, H., Varon, R., Hadac, J., Butova, O.,
Schrock, E., Seeman, P., and Digweed, M. (2006). Nijmegen breakage
syndrome (NBS) with neurological abnormalities and without chromosomal
instability. J. Med. Genet. 43, 218–224.
Shima, H., Suzuki, M., and Shinohara, M. (2005). Isolation and characterization
of novel xrs2 mutations in Saccharomyces cerevisiae. Genetics 170, 71–85.
Shin, D.S., Pellegrini, L., Daniels, D.S., Yelent, B., Craig, L., Bates, D., Yu, D.S.,
Shivji, M.K., Hitomi, C., Arvai, A.S., et al. (2003). Full-length archaeal Rad51
structure and mutants: mechanisms for RAD51 assembly and control by
BRCA2. EMBO J. 22, 4566–4576.
Spycher, C., Miller, E.S., Townsend, K., Pavic, L., Morrice, N.A., Janscak, P.,
Stewart, G.S., and Stucki, M. (2008). Constitutive phosphorylation of MDC1
physically links the MRE11-RAD50-NBS1 complex to damaged chromatin.
J. Cell Biol. 181, 227–240.
Stewart, G.S., Maser, R.S., Stankovic, T., Bressan, D.A., Kaplan, M.I., Jaspers,
N.G., Raams, A., Byrd, P.J., Petrini, J.H., and Taylor, A.M. (1999). The DNA
double-strand break repair gene hMRE11 is mutated in individuals with an
ataxia-telangiectasia-like disorder. Cell 99, 577–587.
Stucki, M., Clapperton, J.A., Mohammad, D., Yaffe, M.B., Smerdon, S.J., and
Jackson, S.P. (2005). MDC1 directly binds phosphorylated histone H2AX
to regulate cellular responses to DNA double-strand breaks. Cell 123,
1213–1226.
Stucki, M., and Jackson, S.P. (2006). gammaH2AX and MDC1: anchoring the
DNA-damage-response machinery to broken chromosomes. DNA Repair
(Amst.) 5, 534–543.
Williams, R.S., Green, R., and Glover, J.N. (2001). Crystal structure of the
BRCT repeat region from the breast cancer-associated protein BRCA1. Nat.
Struct. Biol. 8, 838–842.
Williams, R.S., Lee,M.S., Hau, D.D., andGlover, J.N. (2004). Structural basis of
phosphopeptide recognition by the BRCT domain of BRCA1. Nat. Struct. Mol.
Biol. 11, 519–525.
Williams, R.S., Williams, J.S., and Tainer, J.A. (2007). Mre11-Rad50-Nbs1 is
a keystone complex connecting DNA repair machinery, double-strand break
signaling, and the chromatin template. Biochem. Cell Biol. 85, 509–520.
Williams, R.S., Moncalian, G., Williams, J.S., Yamada, Y., Limbo, O., Shin,
D.S., Groocock, L.M., Cahill, D., Hitomi, C., Guenther, G., et al. (2008).
Mre11 dimers coordinate DNA end bridging and nuclease processing in
double-strand-break repair. Cell 135, 97–109.
Wu, L., Luo, K., Lou, Z., and Chen, J. (2008). MDC1 regulates intra-S-phase
checkpoint by targeting NBS1 to DNA double-strand breaks. Proc. Natl.
Acad. Sci. USA 105, 11200–11205.
You, Z., Chahwan, C., Bailis, J., Hunter, T., and Russell, P. (2005). ATM activa-
tion and its recruitment to damaged DNA require binding to the C terminus of
Nbs1. Mol. Cell. Biol. 25, 5363–5379.
Zhu, Z., Chung, W.H., Shim, E.Y., Lee, S.E., and Ira, G. (2008). Sgs1 helicase
and two nucleases Dna2 and Exo1 resect DNA double-strand break ends. Cell
134, 981–994.Cell 139, 87–99, October 2, 2009 ª2009 Elsevier Inc. 99
